[1] American Diabetes Association.Standards of medical care in diabetes-2011[J].Diabetes Care,2011,34(suppl 1):11-61.
[2] Cockcroft DW,Gault MH.Prediction of creatinine clearance from serum creatinine[J].Nephron,1976,16(1):31-41.
[3] Ahola AJ,Saraheimo M,Forsblom C,et al.Health-related quality of life in patients with type 1 diabetes-association with diabetic complications (the FinnDiane Study)[J].Nephrol Dial Transplant,2010,25(6):1903-1908.
[4] Zhao Y,Ye W,Boye KS,et al.Prevalence of other diabetes-associated complications and comorbidities and its impact on health care charges among patients with diabetic neuropathy[J].J Diabetes Complications,2010,24(1):9-19.
[5] Ahola AJ,Saraheimo M,Forsblom C,et al.The cross-sectional associations between sense of coherence and diabetic microvascular complications,glycaemic control,and patients conceptions of type 1 diabetes[J].Health Qual Life Outcomes,2010,8(2):142.
[6] 宋效成,岳 丽,沈雅庭,等.糖尿病肾病的发生与防治[J].东南国防医药,2008,10(5):361-363.
[7] Bosman DR,Winkler AS,Marsden JT,et al.Anemia with erythropoietin deficiency occurs early in diabetic nephropathy[J].Diabetes Care,2001,24(3):495-499.
[8] 李海斌,杨生健,蔡春茂,等.甲钴胺和银杏叶联合治疗老年糖尿病周围神经病变22例 [J].东南国防医药,2011,13(4):362.
[9] Davies M,Brophy S,Williams R,et al.The prevalence,severity,and impact of painful diabetic peripheral neuropathy in type 2 diabetes[J].Diabetes Care,2006,29(7):1518-1522.
[10] Valiatti FB,Crispim D,Benfica C,et al.The role of vascular endothelial growth factor in angiogenesis and diabetic retinopathy[J].Arq Bras Endocrinol Metabol,2011,55(2):106-113.